Development of immunoradiometric assay for quantitative determination of free prostate-specific antigen

Jugoslovenska Medicinska Biohemija

Volumn 24, Issue 2, 2005, Pages 129-134

  Janković, Miroslava M ^a   Kosanović, Maja M ^a   Hajduković Dragojlović, Ljiljana D ^a   Golubović, Snežana J ^a  

^a Inst Applic Nucl Energy INEP

Author keywords

Anti PSA antibodies; Free PSA; Immunoassay; Standardization

Indexed keywords

ANTIBODY; EPITOPE; PROSTATE SPECIFIC ANTIGEN; TRACER;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ARTICLE; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; MOUSE; NONHUMAN; PROSTATE DISEASE; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; RELIABILITY; STANDARDIZATION;

ANIMALIA;

EID: 17144401116     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0502129J     Document Type: Article

References (16)

1. Diamandis C, Yousef GM, Luo L, Magklara A, Obiezu CV. The new human kallikrein gene family: implications in carcinogenesis. TEM 2000; 11: 54-60.
2. Watt KW, Lee PJ, M Timkulu T, Chan WP, Loor R. Human prostate specific antigen: structural and functional similarity to serine protease. Proc Natl Acad Sci USA 1986; 83: 3166-70.
3. Huber PR, Schimid HP, Mattarelli G, Strittmatter B, van Steenburg GJ, Maurer A. Serum free prostate specific antigen: isoenzymes in benign hyperplasia nad cancer of the prostate. Prostate 1995; 27: 212-9.
4. Hilz H, Noldus J, Hammerer P, Buck F, Luck M, Hulan H. Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors. Eur Urol 1999; 36: 286-92.
5. Stephan C, Jung K, Diamandis E, Rittenhouse HG, Lein M, Loening SA. Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer. Urology 2002; 59: 2-8.
6. Stephan C, Jung K, Lein M, Sinha P, Schnoor D, Loening SA. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer. Canc Epid Biomarkers Prev 2000; 9: 1133-47.
7. Chen Z, Komatsu K, Prestigiacomo A, Stamey T. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by α2-macroglobulin and α1-antichymotrypsin. J Urol 1996; 156: 1357-63.
8. Marinovic V. Prostate-specific antigen: isolation, biochemical characterization and diagnostic potential in prostate-cancer screening. MSc thesis. Belgrade, Serbia and Montenegro; university of Belgrade, 1998.
9. Stenman UH, Paus E, Allard WJ, Andersson I. Andres C, Barnett TR et al. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen. Tumour Biol 1999; 20: 1-12.
10. Stamey TA, Chen Z, Prestigicomo AF. Reference material for PSA: the IFCC standardization study. Clin Biochem 1998;31:475-81.
11. 131I labelled growth hormone of high specific radioactivity. Biochem J 1963; 89: 114-20.
12. Price CP, Newman DJ, eds. Principles and practice of immunoassay London: Macmillan reference LTD, 1997.
13. Iwakiri J, Granbois K, Wehner N, Graves HC, Stamey T. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J Urol 1993; 149: 783-6.
14. Golubović S, Janković M, Gruden-Movsesijan A, Hajduković Lj. Standardization of heterogenous antigens ammunoassays. In: Society of Nuclear Medicine of Serbia and Montenegro, eds. Quality Control. Proceedings of the Congress of Nuclear Medicine, Serbia and Montenegro: 2003 Sept 24-27; Vrnjačka Banja, 2003: 93.
15. Isono T, Tanaka T, Kageyama S, Yoshiki T. Structural diversity of cancer-related and non-cancer related prostate-specific antigen. Clin Chem 2002; 48: 2187-94.
16. Woodrum DL, Brawer MK, Partin AW, Catalona WJ, Southwick PC. Interpretation of free PSA clinical reaserch studies for the detection of prostate cancer. J Urol 1998; 159: 5-12.